Comparison of selection pressures on the HA gene of pandemic (2009) and seasonal human and swine influenza A H1 subtype viruses

Virology

Volumn 405, Issue 2, 2010, Pages 314-321

  Furuse, Yuki ^a   Shimabukuro, Kozue ^a   Odagiri, Takashi ^a   Sawayama, Rumi ^a   Okada, Takashi ^a   Khandaker, Irona ^a   Suzuki, Akira ^a   Oshitani, Hitoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Evolution; Hemagglutinin; Influenza; Pandemic; Phylogeny

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; EVOLUTIONARY RATE; GENETIC ANALYSIS; GENETIC SELECTION; HUMAN; INFLUENZA VIRUS A H1N1; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PHYLOGENETIC TREE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEQUENCE ANALYSIS; SEQUENCE DATABASE; SWINE INFLUENZA; SWINE INFLUENZA VIRUS;

ANIMALS; DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; SEASONS; SELECTION, GENETIC; SWINE; SWINE DISEASES;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77955653801     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.018     Document Type: Article

References (56)

1. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55(4):539-552.
2. Bao Y., Bolotov P., Dernovoy D., Kiryutin B., Zaslavsky L., Tatusova T., Ostell J., Lipman D. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 2008, 82(2):596-601.
3. Campo D.S., Dimitrova Z., Mitchell R.J., Lara J., Khudyakov Y. Coordinated evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 2008, 105(28):9685-9690.
4. Childs R.A., Palma A.S., Wharton S., Matrosovich T., Liu Y., Chai W., Campanero-Rhodes M.A., Zhang Y., Eickmann M., Kiso M., Hay A., Matrosovich M., Feizi T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 2009, 27(9):797-799.
5. de Jong J.C., Smith D.J., Lapedes A.S., Donatelli I., Campitelli L., Barigazzi G., Van Reeth K., Jones T.C., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J. Virol. 2007, 81(8):4315-4322.
6. Earp L.J., Delos S.E., Park H.E., White J.M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 2005, 285:25-66.
7. Fitch W.M., Bush R.M., Bender C.A., Cox N.J. Long term trends in the evolution of H(3) HA1 human influenza type A. Proc. Natl. Acad. Sci. USA 1997, 94(15):7712-7718.
8. Furuse Y., Suzuki A., Kamigaki T., Oshitani H. Evolution of the M gene of the influenza A virus in different host species: Large-scale sequence analysis. Virol. J. 2009, 6(1):67.
9. Furuse Y., Suzuki A., Oshitani H. Reassortment between swine influenza A viruses increased their adaptation to humans in pandemic H1N1/09. Infect. Genet. Evol. 2010.
10. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 1999, 258(2):232-239.
11. Gamblin S.J., Haire L.F., Russell R.J., Stevens D.J., Xiao B., Ha Y., Vasisht N., Steinhauer D.A., Daniels R.S., Elliot A., Wiley D.C., Skehel J.J. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004, 303(5665):1838-1842.
12. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
13. Gerhard W., Yewdell J., Frankel M.E., Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981, 290(5808):713-717.
14. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 2009, 361(20):1945-1952.
15. Hay A.J., Gregory V., Douglas A.R., Lin Y.P. The evolution of human influenza viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356(1416):1861-1870.
16. Composition of the Influenza Vaccine 2009, Health Protection Agency.
17. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326(5953):734-736.
18. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146(12):2275-2289.
19. Igarashi M., Ito K., Kida H., Takada A. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 2008, 376(2):323-329.
20. Igarashi M., Ito K., Yoshida R., Tomabechi D., Kida H., Takada A. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 2010, 5(1):e8553.
21. Inoue E., Wang X., Osawa Y., Okazaki K. Full genomic amplification and subtyping of influenza A virus using a single set of universal primers. Microbiol. Immunol. 2010, 54(3):129-134.
22. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 1998, 72(9):7367-7373.
23. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Yamada S., Fujii K., Murakami S., Imai H., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Warshauer D., Shult P.A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K., Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(7258):1021-1025.
24. Kida H., Ito T., Yasuda J., Shimizu Y., Itakura C., Shortridge K.F., Kawaoka Y., Webster R.G. Potential for transmission of avian influenza viruses to pigs. J. Gen. Virol. 1994, 75(Pt 9):2183-2188.
25. Kilbourne E.D., Smith C., Brett I., Pokorny B.A., Johansson B., Cox N. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc. Natl. Acad. Sci. U S A 2002, 99(16):10748-10752.
26. Kobasa D., Takada A., Shinya K., Hatta M., Halfmann P., Theriault S., Suzuki H., Nishimura H., Mitamura K., Sugaya N., Usui T., Murata T., Maeda Y., Watanabe S., Suresh M., Suzuki T., Suzuki Y., Feldmann H., Kawaoka Y. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004, 431(7009):703-707.
27. Kosakovsky Pond S.L., Frost S.D.W. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 2005, 22(5):1208-1222.
28. Kumar S., Nei M., Dudley J., Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 2008, 9(4):299-306.
29. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., Donatelli I., Kawaoka Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 2000, 74(18):8502-8512.
30. Mehle A., Doudna J.A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl. Acad. Sci. U S A 2009, 106(50):21312-21316.
31. Nobusawa E., Aoyama T., Kato H., Suzuki Y., Tateno Y., Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991, 182(2):475-485.
32. Pond S.L.K., Frost S.D.W., Grossman Z., Gravenor M.B., Richman D.D., Brown A.J.L. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput. Biol. 2006, 2(6):e62.
33. Pond, S. L. K., Poon, A. F. Y., and Frost, S. D. W. (2007). Estimating selection pressures on alignments of coding sequences. Analyses using HyPhy, Vol. 2008.
34. Raymond F.L., Caton A.J., Cox N.J., Kendal A.P., Brownlee G.G. The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology 1986, 148(2):275-287.
35. Reid A.H., Janczewski T.A., Lourens R.M., Elliot A.J., Daniels R.S., Berry C.L., Oxford J.S., Taubenberger J.K. 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants. Emerg. Infect. Dis. 2003, 9(10):1249-1253.
36. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Daniels R.S., Webster R.G., Schild G.C. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology 1987, 160(1):31-37.
37. Rogers G.N., Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127(2):361-373.
38. Schulze I.T. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J. Infect. Dis. 1997, 176(Suppl 1):S24-S28.
39. Shen J., Ma J., Wang Q. Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918. PLoS ONE 2009, 4(11):e7789.
40. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
41. Smith G.J.D., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S.M., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459(7250):1122-1125.
42. Steinhauer D.A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999, 258(1):1-20.
43. Stevens J., Corper A.L., Basler C.F., Taubenberger J.K., Palese P., Wilson I.A. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 2004, 303(5665):1866-1870.
44. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 2006, 355(5):1143-1155.
45. Sugita S., Yoshioka Y., Itamura S., Kanegae Y., Oguchi K., Gojobori T., Nerome K., Oya A. Molecular evolution of hemagglutinin genes of H1N1 swine and human influenza A viruses. J. Mol. Evol. 1991, 32(1):16-23.
46. Suzuki Y. Natural selection on the influenza virus genome. Mol. Biol. Evol. 2006, 23(10):1902-1911.
47. Suzuki Y. Positive selection operates continuously on hemagglutinin during evolution of H3N2 human influenza A virus. Gene 2008, 427(1-2):111-116.
48. Suzuki Y., Gojobori T. A method for detecting positive selection at single amino acid sites. Mol. Biol. Evol. 1999, 16(10):1315-1328.
49. Pandemic (H1N1) 2009 - update 82, Vol. 2010 2010, The World Health Organizaion.
50. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Basler C.F. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. U S A 2004, 101(9):3166-3171.
51. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., Cox N.J., Swayne D.E., Palese P., Katz J.M., Garcia-Sastre A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007, 315(5812):655-659.
52. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 1992, 56(1):152-179.
53. Wei C.J., Boyington J.C., Dai K., Houser K.V., Pearce M.B., Kong W.P., Yang Z.Y., Tumpey T.M., Nabel G.J. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2010, 2(24):24ra21.
54. Xu X., Rocha E.P., Regenery H.L., Kendal A.P., Cox N.J. Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. Virus Res. 1993, 28(1):37-55.
55. Yang H., Carney P., Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. Influenza 2010, RRN1152.
56. Zhirnov O.P., Vorobjeva I.V., Saphonova O.A., Poyarkov S.V., Ovcharenko A.V., Anhlan D., Malyshev N.A. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J. Clin. Virol. 2009, 45(4):322-333.